Shared Spectral Parameters Between EEG and Basal Ganglia LFP Distinguish Sleep-Specific Oscillations in Parkinson's Disease.

Authors

Lisa Hirt, Ruby Martini, Siqun Tang, Michael Summers, Lesile West, Clete Kushida, Stephen V Gliske, Dulce Maroni, Younghoon Nho, Casey H Halpern, Aviva Abosch, John A Thompson

Published in

European journal of neurology. Volume 33. Issue 9. Pages e70733.

Abstract

In Parkinson's disease (PD), sleep-related oscillatory dynamics between basal ganglia and cortical nodes may inform sleep dysfunction. The subthalamic nucleus (STN) is highly interconnected with human sleep circuitry and is a current target of interest for sleep neuromodulation.
To investigate correlated cortical-subcortical activity, we recorded simultaneous PSG and STN local field potentials (LFP) in 19 patients undergoing deep brain stimulation (DBS) for PD. We evaluated the correlation in spectral power between STN-LFP and EEG during polysomnogram (PSG)-defined stages of sleep. In addition, we analyzed aperiodic 1/f spectral parameters (exponent and offset), which have been identified as markers of arousal across sleep stages. Finally, we trained classifiers on aperiodic features to test whether 1/f structure alone could recover PSG-defined sleep stages from EEG and STN-LFP.
Results revealed a significant interaction between recording modality and sleep stage. During wakefulness and REM sleep, STN-LFP exhibited a significantly steeper spectral slope compared to scalp EEG. However, this dissociation diminished with sleep depth; slopes appeared more similar during N2 and reversed during N3, where EEG became steeper than LFP. Across subjects, the aperiodic component showed robust state dependence and modality differences with STN-LFP maintaining higher exponents overall. STN-LFP aperiodic features alone classified sleep stages above chance and outperformed scalp EEG, approaching the combined-modality ceiling.
These findings highlight distinct subcortical electrophysiological signatures in sleep-dependent regulation of neural arousal across brain networks in PD. These insights offer potential biomarkers for both invasive and non-invasive forms of closed-loop neuromodulation strategies targeting sleep dysfunction.
ClinicalTrials.gov identifier: NCT04620551.

PMID:
42656011
Bibliographic data and abstract were imported from PubMed on 27 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.